| Darlonda Harris, MD | |
|
1902 S Morrison Blvd, Hammond, LA 70403-5742 | |
| (985) 230-5800 | |
| (985) 230-5859 |
| Full Name | Darlonda Harris |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 1902 S Morrison Blvd, Hammond, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366784159 | NPI | - | NPPES |
| Entity Name | Family First Medical & Wellness Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992367791 PECOS PAC ID: 9436580057 Enrollment ID: O20200515000799 |
News Archive
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
BATS Global Markets, a global stock market operator, reports the BATS 1000 Index advanced 0.3% for the week ending March 4 in the U.S. The S&P 500 Index was up 0.1% for the same period.
An international research team within the MetaHIT consortium coordinated by INRA and involving teams from CEA, CNRS and Université d'Evry, has developed a new method to analyse the global genome, or the metagenome of the intestinal microbiota.
Data from the independent KYOTO HEART study, presented recently at the European Society of Cardiology (ESC) Congress in Barcelona, Spain, and published online in the European Heart Journal demonstrated the addition of the angiotensin receptor blocker (ARB) Diovan (valsartan) to a non-ARB-based treatment regimen for high blood pressure provided a significant 45% relative risk reduction in cardiovascular events(1) including stroke, compared to conventional non-ARB treatment regimen.(1)
A recent US study showed that in order to prevent or largely extinguish the coronavirus disease 2019 (COVID-19) outbreak without social distancing or any other measures, any vaccine would have to have an efficacy of at least 70%. The research paper is currently available on the medRxiv* preprint server.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darlonda Harris, MD 117 River Point Dr, Destrehan, LA 70047-4008 Ph: (985) 764-6748 | Darlonda Harris, MD 1902 S Morrison Blvd, Hammond, LA 70403-5742 Ph: (985) 230-5800 |
News Archive
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
BATS Global Markets, a global stock market operator, reports the BATS 1000 Index advanced 0.3% for the week ending March 4 in the U.S. The S&P 500 Index was up 0.1% for the same period.
An international research team within the MetaHIT consortium coordinated by INRA and involving teams from CEA, CNRS and Université d'Evry, has developed a new method to analyse the global genome, or the metagenome of the intestinal microbiota.
Data from the independent KYOTO HEART study, presented recently at the European Society of Cardiology (ESC) Congress in Barcelona, Spain, and published online in the European Heart Journal demonstrated the addition of the angiotensin receptor blocker (ARB) Diovan (valsartan) to a non-ARB-based treatment regimen for high blood pressure provided a significant 45% relative risk reduction in cardiovascular events(1) including stroke, compared to conventional non-ARB treatment regimen.(1)
A recent US study showed that in order to prevent or largely extinguish the coronavirus disease 2019 (COVID-19) outbreak without social distancing or any other measures, any vaccine would have to have an efficacy of at least 70%. The research paper is currently available on the medRxiv* preprint server.
› Verified 8 days ago
Dr. Claude T Nesser, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 16070 Doctors Blvd, Hammond, LA 70403 Phone: 985-542-5972 Fax: 985-318-3417 | |
Dr. David Nelson Oubre, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15752 Medical Arts Plaza, Suite 101, Hammond, LA 70403 Phone: 985-419-0025 Fax: 985-419-0035 | |
Dr. Rainier Batiste, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15790 Paul Vega Md Dr, Hammond, LA 70403 Phone: 985-230-3066 Fax: 985-230-2072 | |
Susan Zacharia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15813 Paul Vega Md Dr Ste 300, Hammond, LA 70403 Phone: 985-230-7675 Fax: 985-230-7677 | |
Dr. Michael A Ballard, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 13135 E Adams Rd, Hammond, LA 70403 Phone: 985-969-0084 Fax: 985-643-9808 | |
Corey Steven Majors, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15813 Paul Vega Md Dr Ste 300a, Hammond, LA 70403 Phone: 985-230-7195 Fax: 985-230-7196 | |
Kyle Lance Caulfield, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 42388 Pelican Professional Park, Hammond, LA 70403 Phone: 985-542-6251 Fax: 985-345-2386 |